Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14321)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boland ML, Oró D, Tølbøl KS, Thrane ST, Nielsen JC, Cohen TS, Tabor DE, Fernandes F, Tovchigrechko A, Veidal SS, Warrener P, Sellman BR, Jelsing J, Feigh M, Vrang N, Trevaskis JL, Hansen HH. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World J Gastroenterol 2019; 25(33): 4904-4920 [PMID: 31543682 DOI: 10.3748/wjg.v25.i33.4904] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v25/i33/4904.htm |
| Number | Citing Articles |
| 1 |
Xiankang Fang, Zhiqiang Du, Chunling Duan, Shanshan Zhan, Tian Wang, Mengyu Zhu, Jiajie Shi, Juan Meng, Xianhua Zhang, Maiyun Yang, Yajun Zuo. Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model. Life Sciences 2021; 270: 118966 doi: 10.1016/j.lfs.2020.118966
|
| 2 |
Huan Xue, Hao-Jie Xing, Bin Wang, Chao Fu, Yu-Shan Zhang, Xi Qiao, Chao Guo, Xiao-Li Zhang, Bin Hu, Xin Zhao, Li-Jiao Deng, Xiao-Chan Zhu, Yi Zhang, Yun-Feng Liu. Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis. Drug Design, Development and Therapy 2023; : 1417 doi: 10.2147/DDDT.S404055
|
| 3 |
Yuko Tsukahara, Beatriz Ferran, Erika T. Minetti, Brian S. H. Chong, Adam C. Gower, Markus M. Bachschmid, Reiko Matsui. Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. Antioxidants 2022; 11(5): 867 doi: 10.3390/antiox11050867
|
| 4 |
Jose E. Heredia, Clara Sorenson, Sean Flanagan, Victor Nunez, Charles Jones, Angela Martzall, Laurie Leong, Andres Paler Martinez, Alexis Scherl, Hans D. Brightbill, Nico Ghilardi, Ning Ding, Aloysious Dominic Aravinthan. IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models. PLOS ONE 2022; 17(9): e0274582 doi: 10.1371/journal.pone.0274582
|
| 5 |
Ruiling Wu, Theeraphop Prachyathipsakul, Jiaming Zhuang, Hongxu Liu, Yanhui Han, Bin Liu, Shuai Gong, Jingyi Qiu, Siu Wong, Alexander Ribbe, Jewel Medeiros, Jayashree Bhagabati, Jingjing Gao, Peidong Wu, Ranit Dutta, Roman Herrera, Steve Faraci, Hang Xiao, S Thayumanavan, David Brenner. Conferring liver selectivity to a thyromimetic using a novel nanoparticle increases therapeutic efficacy in a diet-induced obesity animal model. PNAS Nexus 2023; 2(8) doi: 10.1093/pnasnexus/pgad252
|
| 6 |
James M. Eng, Jennifer L. Estall. Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol. Cells 2021; 10(7): 1805 doi: 10.3390/cells10071805
|
| 7 |
John J. Nestor, David Parkes, Michael Feigh, John J. Suschak, M. Scott Harris. Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10577-2
|
| 8 |
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm. International Journal of Molecular Sciences 2022; 23(23): 14762 doi: 10.3390/ijms232314762
|
| 9 |
Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, Chen Zhang, Martin Rønn Madsen, Andreas Nygaard Madsen, Jenny Norlin, Michael Feigh, Steen Larsen, Henrik H. Hansen. Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03141-x
|
| 10 |
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, Enrico Focaccia, Mohammad Rahbari, Adnan Ali, Nisar P. Malek, Quentin M. Anstee, Mathias Heikenwalder. A researcher’s guide to preclinical mouse NASH models. Nature Metabolism 2022; 4(12): 1632 doi: 10.1038/s42255-022-00700-y
|
| 11 |
Simon T. Hui, Feng Wang, Frank Stappenbeck, Samuel W. French, Clara E. Magyar, Farhad Parhami, Aldons J. Lusis. Oxy210, a novel inhibitor of hedgehog and TGF‐β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice. Endocrinology, Diabetes & Metabolism 2021; 4(4) doi: 10.1002/edm2.296
|
| 12 |
Kristine Griffett, Matthew E. Hayes, Michael P. Boeckman, Thomas P. Burris. The role of REV-ERB in NASH. Acta Pharmacologica Sinica 2022; 43(5): 1133 doi: 10.1038/s41401-022-00883-w
|
| 13 |
Sawa Miyagawa, Takahiro Horie, Tomohiro Nishino, Satoshi Koyama, Toshimitsu Watanabe, Osamu Baba, Tomohiro Yamasaki, Naoya Sowa, Chiharu Otani, Kazuki Matsushita, Hidenori Kojima, Masahiro Kimura, Yasuhiro Nakashima, Satoshi Obika, Yuuya Kasahara, Jun Kotera, Kozo Oka, Ryo Fujita, Takashi Sasaki, Akihiro Takemiya, Koji Hasegawa, Takeshi Kimura, Koh Ono. Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis. Life Science Alliance 2023; 6(8): e202301902 doi: 10.26508/lsa.202301902
|
| 14 |
Rocío Montero‐Vallejo, Douglas Maya‐Miles, Javier Ampuero, Franz Martín, Manuel Romero‐Gómez, Rocío Gallego‐Durán. Novel insights into metabolic‐associated steatotic liver disease preclinical models. Liver International 2024; 44(3): 644 doi: 10.1111/liv.15830
|
| 15 |
Hannah Zhang, Mélissa Léveillé, Emilie Courty, Aysim Gunes, Bich N. Nguyen, Jennifer L. Estall. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease. American Journal of Physiology-Endocrinology and Metabolism 2020; 319(5): E863 doi: 10.1152/ajpendo.00321.2020
|
| 16 |
Henrik H. Hansen, Susanne Pors, Maja W. Andersen, Mogens Vyberg, Jacob Nøhr-Meldgaard, Malte Hasle Nielsen, Denise Oró, Martin Rønn Madsen, Monika Lewinska, Mathias B. Møllerhøj, Andreas Nygaard Madsen, Michael Feigh. Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-50328-5
|
| 17 |
Samuel M. Lee, Jose Muratalla, Saman Karimi, Alberto Diaz-Ruiz, Maria Dolores Frutos, Grace Guzman, Bruno Ramos-Molina, Jose Cordoba-Chacon. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cellular and Molecular Life Sciences 2023; 80(2) doi: 10.1007/s00018-022-04629-z
|
| 18 |
Sridhar Radhakrishnan, Jia-Yu Ke, Michael A Pellizzon. Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models. Current Developments in Nutrition 2020; 4(6): nzaa078 doi: 10.1093/cdn/nzaa078
|
| 19 |
Xuecheng Li, Yi Lu, Xiaoshuang Liang, Xiaofei Zhou, Dirui Li, Zan Zhang, Yunchao Niu, Shuaishuai Liu, Ling Ye, Rufeng Zhang, Gianfranco D. Alpini. A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis. PLOS ONE 2023; 18(5): e0286257 doi: 10.1371/journal.pone.0286257
|
| 20 |
Suraphan Panyod, Wei-Kai Wu, Sin-Yi Peng, Yea-Jing Tseng, Ya-Chi Hsieh, Rou-An Chen, Huai-Syuan Huang, Yi-Hsun Chen, Hsiao-Li Chuang, Cheng-Chih Hsu, Ting-Chin David Shen, Kai-Chien Yang, Chi-Tang Ho, Ming-Shiang Wu, Lee-Yan Sheen. Ginger essential oil and citral ameliorates atherosclerosis in ApoE−/− mice by modulating trimethylamine-N-oxide and gut microbiota. npj Science of Food 2023; 7(1) doi: 10.1038/s41538-023-00196-0
|
| 21 |
Suraphan Panyod, Wei-Kai Wu, Meng-Yun Hu, Huai-Syuan Huang, Rou-An Chen, Yi-Hsun Chen, Ting-Chin David Shen, Chi-Tang Ho, Chun-Jen Liu, Hsiao-Li Chuang, Chi-Chang Huang, Ming-Shiang Wu, Lee-Yan Sheen, Wei-Hua Chen. Healthy diet intervention reverses the progression of NASH through gut microbiota modulation. Microbiology Spectrum 2024; 12(1) doi: 10.1128/spectrum.01868-23
|
| 22 |
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926
|
| 23 |
Christina-Maria Flessa, Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, Harpal S. Randeva. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. International Journal of Molecular Sciences 2022; 23(24): 15791 doi: 10.3390/ijms232415791
|
| 24 |
Bridget S. Gosis, Shogo Wada, Chelsea Thorsheim, Kristina Li, Sunhee Jung, Joshua H. Rhoades, Yifan Yang, Jeffrey Brandimarto, Li Li, Kahealani Uehara, Cholsoon Jang, Matthew Lanza, Nathan B. Sanford, Marc R. Bornstein, Sunhye Jeong, Paul M. Titchenell, Sudha B. Biddinger, Zoltan Arany. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science 2022; 376(6590) doi: 10.1126/science.abf8271
|
| 25 |
Shintaro Hamada, Tomoaki Takata, Kentaro Yamada, Marie Yamamoto, Yukari Mae, Takuji Iyama, Suguru Ikeda, Tsutomu Kanda, Takaaki Sugihara, Hajime Isomoto, David Long. Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model. PLOS ONE 2022; 17(3): e0265461 doi: 10.1371/journal.pone.0265461
|
| 26 |
Sridhar Radhakrishnan, Steven F Yeung, Jia-Yu Ke, Maísa M Antunes, Michael A Pellizzon. Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models. Current Developments in Nutrition 2021; 5(12): nzab138 doi: 10.1093/cdn/nzab138
|
| 27 |
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
|
| 28 |
Jarren R. Oates, Keisuke Sawada, Daniel A. Giles, Pablo C. Alarcon, Michelle S.M.A. Damen, Sara Szabo, Traci E. Stankiewicz, Maria E. Moreno-Fernandez, Senad Divanovic. Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1095132
|
| 29 |
Michiko Itoh, Atsushi Tamura, Sayaka Kanai, Miyako Tanaka, Yohei Kanamori, Ibuki Shirakawa, Ayaka Ito, Yasuyoshi Oka, Isao Hidaka, Taro Takami, Yasushi Honda, Mitsuyo Maeda, Yasuyuki Saito, Yoji Murata, Takashi Matozaki, Atsushi Nakajima, Yosky Kataoka, Tomoo Ogi, Yoshihiro Ogawa, Takayoshi Suganami. Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH. Journal of Experimental Medicine 2023; 220(11) doi: 10.1084/jem.20220681
|
| 30 |
Jia Han, Xin Guo, Tomoyuki Koyama, Daichi Kawai, Jing Zhang, Reimon Yamaguchi, Xiaolei Zhou, Yoshiharu Motoo, Takumi Satoh, Sohsuke Yamada. Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model. Nutrients 2021; 13(10): 3455 doi: 10.3390/nu13103455
|
| 31 |
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
|
| 32 |
Wenwen Yang, Rui Guo, Aiwen Pi, Qinchao Ding, Liuyi Hao, Qing Song, Lin Chen, Xiaobing Dou, Lixin Na, Songtao Li. Long non-coding RNA-EN_181 potentially contributes to the protective effects of N-acetylcysteine against non-alcoholic fatty liver disease in mice. British Journal of Nutrition 2023; 129(6): 921 doi: 10.1017/S0007114522001829
|
| 33 |
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
|
| 34 |
Brett E. Phillips, Louise Lantier, Carl Engman, Yesica Garciafigueroa, Aatur Singhi, Massimo Trucco, Christos Mantzoros, David Wasserman, Nick Giannoukakis. Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist. Cardiovascular Diabetology 2022; 21(1) doi: 10.1186/s12933-022-01564-y
|
| 35 |
Yusei Hosokawa, Tetsuya Hosooka, Makoto Imamori, Kanji Yamaguchi, Yoshito Itoh, Wataru Ogawa. Adipose tissue insulin resistance exacerbates liver inflammation and fibrosis in a diet-induced NASH model. Hepatology Communications 2023; 7(6) doi: 10.1097/HC9.0000000000000161
|
| 36 |
Leo Sungwong Choi, In Geun Jo, Ku Suk Kang, Jeong Ho Im, Jiyoung Kim, Jinyoung Kim, Jin Wook Chung, Sang-Ku Yoo. Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity. International Journal of Obesity 2021; 45(1): 130 doi: 10.1038/s41366-020-00686-1
|
| 37 |
Yuan Xie, Lu Chen, Zhipeng Xu, Chen Li, Yangyue Ni, Min Hou, Lin Chen, Hao Chang, Yuxuan Yang, Huiquan Wang, Rongbo He, Rourou Chen, Li Qian, Yan Luo, Ying Zhang, Na Li, Yuxiao Zhu, Minjun Ji, Yu Liu. Predictive Modeling of MAFLD Based on Hsp90α and the Therapeutic Application of Teprenone in a Diet-Induced Mouse Model. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.743202
|
| 38 |
Simon T. Hui, Lili Gong, Chantle Swichkow, Montgomery Blencowe, Dorota Kaminska, Graciel Diamante, Calvin Pan, Meet Dalsania, Samuel W. French, Clara E. Magyar, Päivi Pajukanta, Jussi Pihlajamäki, Kristina I. Boström, Xia Yang, Aldons J. Lusis. Role of Matrix Gla Protein in Transforming Growth Factor-β Signaling and Nonalcoholic Steatohepatitis in Mice. Cellular and Molecular Gastroenterology and Hepatology 2023; 16(6): 943 doi: 10.1016/j.jcmgh.2023.08.007
|
| 39 |
Fangli Zhou, Xiaoli Sun. Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.762828
|
| 40 |
Bader Zarrouki, Jeremie Boucher. Kupffer Cells. Methods in Molecular Biology 2020; 2164: 121 doi: 10.1007/978-1-0716-0704-6_13
|
| 41 |
Xiaojing Wang, Liangjing Wang, Lin Geng, Naoki Tanaka, Bin Ye. Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner. International Journal of Molecular Sciences 2023; 24(6): 5843 doi: 10.3390/ijms24065843
|
| 42 |
Maria E. Moreno-Fernandez, Daniel A. Giles, Jarren R. Oates, Calvin C. Chan, Michelle S.M.A. Damen, Jessica R. Doll, Traci E. Stankiewicz, Xiaoting Chen, Kashish Chetal, Rebekah Karns, Matthew T. Weirauch, Lindsey Romick-Rosendale, Stavra A. Xanthakos, Rachel Sheridan, Sara Szabo, Amy S. Shah, Michael A. Helmrath, Thomas H. Inge, Hitesh Deshmukh, Nathan Salomonis, Senad Divanovic. PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. Cell Metabolism 2021; 33(6): 1187 doi: 10.1016/j.cmet.2021.04.018
|
| 43 |
Panu K. Luukkonen, Ikki Sakuma, Rafael C. Gaspar, Meghan Mooring, Ali Nasiri, Mario Kahn, Xian-Man Zhang, Dongyan Zhang, Henna Sammalkorpi, Anne K. Penttilä, Marju Orho-Melander, Johanna Arola, Anne Juuti, Xuchen Zhang, Dean Yimlamai, Hannele Yki-Järvinen, Kitt Falk Petersen, Gerald I. Shulman.
Inhibition of
HSD17B13
protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
. Proceedings of the National Academy of Sciences 2023; 120(4) doi: 10.1073/pnas.2217543120
|
| 44 |
Aimo Kannt, Efstathia Papada, Claire Kammermeier, Giuseppe D'Auria, Nuria Jiménez‐Hernández, Martin Stephan, Uwe Schwahn, Andreas Nygaard Madsen, Mette Viberg Østergaard, George Dedoussis, M. Pilar Francino. Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis. Molecular Nutrition & Food Research 2019; 63(24) doi: 10.1002/mnfr.201900927
|
| 45 |
Hu Li, Qingling Wang, Peizhan Chen, Chenghua Zhou, Xinxin Zhang, Li Chen. Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.788558
|
| 46 |
Yuhan Cao, Jingying Shi, Luyao Song, Junjiu Xu, Henglei Lu, Jianhua Sun, Jinjun Hou, Jing Chen, Wanying Wu, Likun Gong. Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.858795
|
| 47 |
Raul C. Camacho, David Polidori, Tao Chen, Bin Chen, Helen Han Hsu, Bin Gao, Mathieu Marella, Mariusz Lubomirski, Traymon Beavers, Javier Cabrera, Peggy Wong, Andrea R. Nawrocki. Validation of a diet‐induced Macaca fascicularis model of non‐alcoholic steatohepatitis with dietary and pioglitazone interventions. Diabetes, Obesity and Metabolism 2023; 25(4): 1068 doi: 10.1111/dom.14955
|
| 48 |
Shuang Wang, Scott L. Friedman. Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH). Science Translational Medicine 2023; 15(716) doi: 10.1126/scitranslmed.adi0759
|
| 49 |
Emma L. Shepherd, Raquel Saborano, Ellie Northall, Kae Matsuda, Hitomi Ogino, Hiroaki Yashiro, Jason Pickens, Ryan E. Feaver, Banumathi K. Cole, Stephen A. Hoang, Mark J. Lawson, Matthew Olson, Robert A. Figler, John E. Reardon, Nobuhiro Nishigaki, Brian R. Wamhoff, Ulrich L. Günther, Gideon Hirschfield, Derek M. Erion, Patricia F. Lalor. Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis. JHEP Reports 2021; 3(2): 100217 doi: 10.1016/j.jhepr.2020.100217
|
| 50 |
Amanda K. Jones, Besnik Bajrami, Morgan K. Campbell, Abdullah Mesut Erzurumluoglu, Qiusha Guo, Hongxing Chen, Xiaomei Zhang, Svetlana Zeveleva, David Kvaskoff, Andreas-David Brunner, Stefanie Muller, Vasudha Gathey, Rajvee M. Dave, James W. Tanner, Sophia Rixen, Michel A. Struwe, Kathryn Phoenix, Kaitlyn J. Klumph, Heather Robinson, Daniel Veyel, Annkatrin Muller, Boris Noyvert, Boris Alexander Bartholdy, Agnes A. Steixner-Kumar, Jan Stutzki, Dmitriy Drichel, Steffen Omland, Ryan Sheehan, Jon Hill, Tom Bretschneider, Dirk Gottschling, Axel J. Scheidig, Bernd Clement, Martin Giera, Zhihao Ding, John Broadwater, Curtis R. Warren. mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000365
|
| 51 |
Hieu Huy Phung, Chang Hoon Lee. Mouse models of nonalcoholic steatohepatitis and their application to new drug development. Archives of Pharmacal Research 2022; 45(11): 761 doi: 10.1007/s12272-022-01410-5
|
| 52 |
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-García, Svenja Sydor, Lars P. Bechmann, Eva Maranillo, José Ramón Sañudo, María Teresa Vázquez, Arantza Lamas-Paz, Laura Morán, Marina S. Mazariegos, Andreea Ciudin, Juan M. Pericàs, María Isabel Peligros, Javier Vaquero, Eduardo Martínez-Naves, Christian Liedtke, José R. Regueiro, Christian Trautwein, Rafael Bañares, Francisco Javier Cubero, Yulia A. Nevzorova. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines 2021; 9(10): 1289 doi: 10.3390/biomedicines9101289
|
| 53 |
Mathias B. Møllerhøj, Sanne S. Veidal, Kirstine Tølbøl Thrane, Denise Oró, Agnete Overgaard, Casper Gravesen Salinas, Martin Rønn Madsen, Larissa Pfisterer, Mogens Vyberg, Eric Simon, Andre Broermann, Niels Vrang, Jacob Jelsing, Michael Feigh, Henrik H. Hansen. Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH. Clinical and Translational Science 2022; 15(5): 1167 doi: 10.1111/cts.13235
|
| 54 |
Vitor de Miranda Ramos, Alicia J. Kowaltowski, Pamela A. Kakimoto. Autophagy in Hepatic Steatosis: A Structured Review. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.657389
|
| 55 |
Jingjing Hu, Yueliang Shen, Yunwen Chen. Metabonomics Application on Screening Serum Biomarkers of Golden
Hamsters with Nonalcoholic Steatohepatitis Induced by High-Fat Diet. Combinatorial Chemistry & High Throughput Screening 2023; 26(13): 2280 doi: 10.2174/1386207326666230223095745
|
| 56 |
Anna Juliane Vesting, Alexander Jais, Paul Klemm, Lukas Steuernagel, Peter Wienand, Morten Fog-Tonnesen, Henning Hvid, Anna–Lena Schumacher, Christian Kukat, Hendrik Nolte, Theodoros Georgomanolis, Janine Altmüller, Manolis Pasparakis, Andreas Schmidt, Marcus Krüger, Marc Schmidt Supprian, Ari Waisman, Beate Katharina Straub, Nathanael Raschzok, Michel Bernier, Andreas L. Birkenfeld, Nadine Hövelmeyer, Jens C. Brüning, F. Thomas Wunderlich. NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. Molecular Metabolism 2022; 66: 101626 doi: 10.1016/j.molmet.2022.101626
|
| 57 |
Lourdes Rodríguez-Fragoso, Anahí Rodríguez-López, Janet Sánchez-Quevedo. Animal Models and Experimental Research in Medicine. 2023; doi: 10.5772/intechopen.106219
|
| 58 |
Malte Hasle Nielsen, Matthew P. Gillum, Niels Vrang, Jacob Jelsing, Henrik H. Hansen, Michael Feigh, Denise Oró. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 324(5): G378 doi: 10.1152/ajpgi.00157.2022
|
| 59 |
Koichi Fujisawa, Taro Takami, Shoki Okubo, Yuto Nishimura, Yusaku Yamada, Keisuke Kondo, Toshihiko Matsumoto, Naoki Yamamoto, Isao Sakaida. Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose. International Journal of Molecular Sciences 2021; 22(18): 9931 doi: 10.3390/ijms22189931
|
| 60 |
Syifa Mustika, Dewi Santosaningsih, Dian Handayani, Achmad Rudijanto. Impact of multiple different high-fat diets on metabolism, inflammatory markers, dysbiosis, and liver histology: study on NASH rat model induced diet. F1000Research 2023; 12: 180 doi: 10.12688/f1000research.129645.1
|
| 61 |
Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, Francois Pattou, Bart Staels, Michael Wagner. Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis. Diabetes, Obesity and Metabolism 2020; 22(8): 1328 doi: 10.1111/dom.14035
|
| 62 |
Anurag Mishra, Tamara R. Castañeda, Erik Bader, Bettina Elshorst, Sheila Cummings, Petra Scherer, Dinesh S. Bangari, Claudia Loewe, Herman Schreuder, Christoph Pöverlein, Mike Helms, Seth Jones, Gernot Zech, Thomas Licher, Michael Wagner, Manfred Schudok, Meltsje de Hoop, Alleyn T. Plowright, Jens Atzrodt, Aimo Kannt, Iina Laitinen, Volker Derdau. Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis. Advanced Science 2020; 7(24) doi: 10.1002/advs.202002997
|
| 63 |
Lorenz M. W. Holzner, Andrew J. Murray. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.753268
|
| 64 |
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
|
| 65 |
Laetitia Coassolo, Tianyun Liu, Yunshin Jung, Nikki P. Taylor, Meng Zhao, Gregory W. Charville, Silas Boye Nissen, Hannele Yki-Jarvinen, Russ B. Altman, Katrin J. Svensson. Mapping transcriptional heterogeneity and metabolic networks in fatty livers at single-cell resolution. iScience 2023; 26(1): 105802 doi: 10.1016/j.isci.2022.105802
|
| 66 |
Evangelia Lekka, Aleksandra Kokanovic, Simone Mosole, Gianluca Civenni, Sandro Schmidli, Artur Laski, Alice Ghidini, Pavithra Iyer, Christian Berk, Alok Behera, Carlo V. Catapano, Jonathan Hall. Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-35481-1
|